Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma - 16/08/11

Amedeo A Azizi, MD ^a, ‡

  These researchers contributed equally to the report

, Christine Haberler, MD ^b, ‡

  These researchers contributed equally to the report

, Thomas Czech, MD ^c, Astrid Gupper, MD ^a, Daniela Prayer, MD ^d, Helene Breitschopf ^e, Till Acker, MD ^f, Irene Slavc, DrMD ^{a, ⁎}

^a Department of Paediatrics, Medical University of Vienna, Währinger Gürtel 18–20, A-1097 Vienna, Austria 

^b Institute of Neurology, Medical University of Vienna, Währinger Gürtel 18–20, A-1097 Vienna, Austria 

^c Department of Neurosurgery, Medical University of Vienna, Währinger Gürtel 18–20, A-1097 Vienna, Austria 

^d Department of Radiology, Medical University of Vienna, Währinger Gürtel 18–20, A-1097 Vienna, Austria 

^e Institute of Brain Research, Medical University of Vienna, Währinger Gürtel 18–20, A-1097 Vienna, Austria 

^f Neurological Institute University of Frankfurt, Frankfurt, Germany 

^* Correspondence to: Dr Irene Slavc